Abstract:To improve the inhibitory selectivity and explore the substitution effect of the Schiff base ligands on the inhibitory effect of the complex against the PTPs, three CA) complexes, [Cu (X-pimp)2] (X-pimp =2-((4-X-phenylimino)methyl) phenol), X=Cl, Br, and Acetyl), were prepared and characterized by X-ray, EA, IR, UV-Vis and ESI-MS. Taking [Cu(Cl-pimp)2] complex as an example, the solution species distribution with different pH values and the main existing form under the pH neutral condition were investigated using both the pH potentiometric and UV titrations, indicating that the ration of Cl-pimp ligand and COO ion in the complex was 2: 1 in an aqueous solution and [Cu(Cl-pimp)(2)H-1](-) is the main existing form in the pH neutral condition. Then the inhibitory activities of these complexes against above-mentioned protein tyrosine phosphatase 1B (PTP1B), T-cell protein tyrosine phosphatase(TCPTP), Src homology phosphatase 1 (SHP-1), and Src homology phosphates 2 (SHP-2) was evaluated using IC50 values. The results revealed that these three complexes showed similar inhibitory behaviours, i.e. potent effect against PTP1B and TCPTP (0.20 mu mol.L-1<IC50<0.31 mu mol.L-1), the relatively lower effect against SHP-1 (2.7 mu mol.L-1<IC50<4.7 mu mol.L-1), while negligible effect against SHP-2 (IC50>100 mu mol.L-1), which indicated that the type of substituents on the papa position of phenylimino of the Schiff base ligand did not influence the inhibitory effect of the complexes against PTPs obviously. However, comparing the current results to that of the above-mentioned previous work, we can find that the change in the position of the substituents may change the selectivity of inhibitory effect of the complexes against PTPs. The interactions between the complexes and PTPs were studied using [Cu(Cl-pimp)(2)] and PTP1B as the representatives. The kinetics assays showed that the complex inhibited PTP1B in a non-competitive mode and the inhibition constant was calculated to be 0.35 mu mol.L-1. The fluorescence titration revealed that the complex bound to PTP1B with the molar ration of 1:1 and the binding constant of 9.3x10(6)L.mol(-1). We infer that the [Cu(Cl-pimp)(2)] complex may bind firmly to inactive area of PTP1B and indirectly lead to the structural changes to the active center, which inhibits the activity of PTP1B.

Dinuclear Copper Complexes of Organic Claw: Potent Inhibition of Protein Tyrosine Phosphatases

Synthesis and Evaluation of Copper Complexes of Schiff-base Condensates from 5-Substituted-2-hydroxybenzaldehyde and 2-Substituted-benzenamine As Selective Inhibitors of Protein Tyrosine Phosphatases

Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives

Potent inhibition of protein tyrosine phosphatases by quinquedentate binuclear copper complexes: synthesis, characterization and biological activities.

Mononuclear copper(II) complexes with 3,5-substituted-4-salicylidene-amino-3,5-dimethyl-1,2,4-triazole: synthesis, structure and potent inhibition of protein tyrosine phosphatases.

Exploration of Zinc(II) Complexes As Potent Inhibitors Against Protein Tyrosine Phosphatase 1B

Potent Inhibition of Protein Tyrosine Phosphatase 1B by Copper Complexes: Implications for Copper Toxicity in Biological Systems

Evaluation of Cu(II) Complexes with Schiff Base of Salicylanilide as the Inhibitors of Protein Tyrosine Phosphatases

Synthesis, Structure and in Vitro Biological Properties of a New Copper(ii) Complex with 4-{[3-(pyridin-2-yl)-1h-pyrazol-1-yl]methyl}benzoic Acid.

Ptps Inhibition by Zinc(Ii) Complexes with Multi-Benzimidazole Derivatives

Synthesis, structure and <i>in vitro</i> biological properties of a new copper(II) complex with 4-{[3-(pyridin-2-yl)-1<i>H</i>-pyrazol-1-yl]methyl}benzoic acid

Synthesis, Crystal Structure and Protein Tyrosine Phosphatase Inhibition of A Copper(Ii) Complex with N-(2-Pyridylmethyl)-L-Serine

A Copper(Ii) Complex Based on N-(4-Hydroxybenzyl)-L-Serine: Synthesis, Crystal Structure and Inhibitory Activity on Ptp1b and Tcptp

Synthesis, X-ray crystal structures, magnetism, and DNA cleavage properties of copper(II) complexes with 1,4-tpbd ligand.

Four New Copper(ii) Complexes with 1,3-Tpbd Ligand: Synthesis, Crystal Structures, Magnetism, Oxidative and Hydrolytic Cleavage of Pbr322 DNA

Identification of 2-substituted ethenesulfonic acid ester derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatase 1B.

Crystal Structure of PTP1B Complexed with a Potent and Selective Bidentate Inhibitor

Dna Binding, Oxidative Dna Cleavage, Cytotoxicity, and Apoptosis-Inducing Activity of Copper(Ii) Complexes with 1,4-Tpbd (N,N,N ',N '-Tetrakis(2-yridylmethyl)benzene-1,4-diamine) Ligand

Synthesis, crystal structure, and PTPs inhibition activity of a { N , S }-coordinated paddle wheel platinum(II) complex

Synthesis and Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitory Activity Evaluation of Novel Arylaminoacetylhydrazone Derivatives Containing Carbazole Moiety

Synthesis and Biological Evaluation of Oleanolic Acid Derivatives As Novel Inhibitors of Protein Tyrosine Phosphatase 1B